Medpace Holdings Goodwill and Intangible Assets 2014-2024 | MEDP

Medpace Holdings goodwill and intangible assets from 2014 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
  • Medpace Holdings goodwill and intangible assets for the quarter ending September 30, 2024 were $0.697B, a 0.23% decline year-over-year.
  • Medpace Holdings goodwill and intangible assets for 2023 were $0.698B, a 0.31% decline from 2022.
  • Medpace Holdings goodwill and intangible assets for 2022 were $0.7B, a 0.48% decline from 2021.
  • Medpace Holdings goodwill and intangible assets for 2021 were $0.704B, a 0.72% decline from 2020.
Medpace Holdings Annual Goodwill and Intangible Assets
(Millions of US $)
2023 $698
2022 $700
2021 $704
2020 $709
2019 $717
2018 $730
2017 $760
2016 $797
2015 $848
2014 $920
2013 $0
Medpace Holdings Quarterly Goodwill and Intangible Assets
(Millions of US $)
2024-09-30 $697
2024-06-30 $697
2024-03-31 $698
2023-12-31 $698
2023-09-30 $699
2023-06-30 $699
2023-03-31 $700
2022-12-31 $700
2022-09-30 $701
2022-06-30 $702
2022-03-31 $703
2021-12-31 $704
2021-09-30 $705
2021-06-30 $706
2021-03-31 $708
2020-12-31 $709
2020-09-30 $711
2020-06-30 $713
2020-03-31 $715
2019-12-31 $717
2019-09-30 $720
2019-06-30 $723
2019-03-31 $726
2018-12-31 $730
2018-09-30 $738
2018-06-30 $745
2018-03-31 $752
2017-12-31 $760
2017-09-30 $769
2017-06-30 $779
2017-03-31 $788
2016-12-31 $797
2016-09-30 $810
2016-06-30 $0
2016-03-31 $0
2015-12-31
2015-09-30 $0
2014-12-31 $920
2013-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Services $11.301B $1.886B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $98.658B 12.24
Cencora (COR) United States $49.082B 18.10
DiDi Global (DIDIY) China $23.427B 0.00
ICON (ICLR) Ireland $17.504B 15.59
Natera (NTRA) United States $16.570B 0.00
Viatris (VTRS) United States $15.624B 4.81
Avantor (AVTR) United States $15.178B 22.75
Revvity (RVTY) United States $14.682B 25.50
BioMerieux (BMXMF) France $13.087B 0.00
CochLear (CHEOY) Australia $12.998B 0.00
Solventum (SOLV) United States $12.357B 0.00
Doximity (DOCS) United States $11.372B 67.31
Charles River Laboratories (CRL) United States $11.285B 21.81
HealthEquity (HQY) United States $8.756B 47.52
Sonic Healthcare (SKHHY) Australia $8.590B 0.00
Bausch + Lomb (BLCO) Canada $7.202B 33.53
Life Times (LTH) United States $5.139B 34.01
Sotera Health (SHC) United States $4.509B 24.12
Organon (OGN) United States $4.144B 4.18
Surgery Partners (SGRY) United States $3.996B 44.27
BrightSpring Health Services (BTSG) United States $3.489B 74.22
PACS (PACS) United States $3.347B 0.00
Alignment Healthcare (ALHC) United States $2.580B 0.00
Concentras Parent (CON) United States $2.505B 0.00
Ardent Health Partners (ARDT) United States $2.471B 0.00
Premier (PINC) United States $2.314B 11.55
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $2.016B 0.00
GoodRx Holdings (GDRX) United States $1.856B 48.90
Teladoc Health (TDOC) United States $1.689B 0.00
Progyny (PGNY) United States $1.540B 27.08
Pediatrix Medical (MD) United States $1.371B 13.41
Establishment Labs Holdings (ESTA) $1.266B 0.00
CareDx (CDNA) United States $1.252B 0.00
AMN Healthcare Services Inc (AMN) United States $1.058B 7.16
Embecta (EMBC) United States $0.910B 6.07
Agilon Health (AGL) United States $0.890B 0.00
InnovAge Holding (INNV) United States $0.809B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.723B 0.00
Auna S.A (AUNA) Luxembourg $0.516B 0.00
Sonida Senior Living (SNDA) United States $0.459B 0.00
DocGo (DCGO) United States $0.411B 15.46
Enhabit (EHAB) United States $0.403B 34.83
COMPASS Pathways (CMPS) United Kingdom $0.363B 0.00
LifeMD (LFMD) United States $0.308B 0.00
Sera Prognostics (SERA) United States $0.248B 0.00
ModivCare (MODV) United States $0.231B 12.54
Beauty Health (SKIN) United States $0.218B 0.00
Biodesix (BDSX) United States $0.205B 0.00
Nutex Health (NUTX) United States $0.152B 0.00
MultiPlan (MPLN) United States $0.137B 0.00
Ascend Wellness Holdings (AAWH) United States $0.107B 0.00
So-Young (SY) China $0.088B 21.28
Singular Genomics Systems (OMIC) United States $0.057B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.054B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.042B 1.10
Co-Diagnostics (CODX) United States $0.038B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00